Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Talis Biomedical Corp (TLIS)

Talis Biomedical Corp (TLIS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,177
  • Shares Outstanding, K 1,823
  • Annual Sales, $ 2,130 K
  • Annual Income, $ -62,010 K
  • EBIT $ -62 M
  • EBITDA $ -61 M
  • 60-Month Beta 1.32
  • Price/Sales 26.59
  • Price/Cash Flow N/A
  • Price/Book 0.11
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -31.43
  • Most Recent Earnings N/A on 08/19/24
  • Next Earnings Date 01/01/70
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.6000 +77.50%
on 12/17/25
2.8400 unch
on 12/18/25
+1.2400 (+77.50%)
since 11/14/25
3-Month
1.1500 +146.96%
on 09/23/25
2.8400 unch
on 12/18/25
+1.3400 (+89.33%)
since 09/18/25
52-Week
1.0400 +173.08%
on 04/21/25
2.8400 unch
on 12/18/25
+1.0000 (+54.35%)
since 12/17/24

Most Recent Stories

More News
Talis Biomedical Corporation (TLIS) Stockholders: Robbins LLP is Investigating TLIS on Behalf of Shareholders

Shareholder rights law firm Robbins LLP is investigating Talis Biomedical Corporation (NASDAQ: TLIS) to determine whether certain Talis officers and directors violated securities laws and breached fiduciary...

TLIS : 2.8400 (+77.50%)
Talis Biomedical Provides Business Update and Reports Second Quarter Financial Results

Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...

TLIS : 2.8400 (+77.50%)
Talis Biomedical Corporation (TLIS) Q1 2022 Earnings Call Transcript

TLIS earnings call for the period ending March 31, 2022.

TLIS : 2.8400 (+77.50%)
Talis Biomedical to Announce First Quarter 2022 Financial Results on May 10, 2022

MENLO PARK, Calif., April 26, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes...

TLIS : 2.8400 (+77.50%)
Talis Biomedical Corporation (TLIS) Q4 2021 Earnings Call Transcript

TLIS earnings call for the period ending December 31, 2021.

TLIS : 2.8400 (+77.50%)
Talis Biomedical Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results

Conference call and webcast today at 4:30pm Eastern/1:30pm Pacific...

TLIS : 2.8400 (+77.50%)
Talis Biomedical to Announce Fourth Quarter and Full Year Financial Results on March 15, 2022

MENLO PARK, Calif., March 01, 2022 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation ("TLIS"), a company dedicated to advancing health equity and outcomes...

TLIS : 2.8400 (+77.50%)
Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Contact the Firm Before March 8, 2022

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Talis...

TLIS : 2.8400 (+77.50%)
INVESTOR ALERT: Kirby McInerney LLP Reminds Investors That a Securities Class Action Lawsuit Has Been Filed on Behalf of Talis Biomedical Corporation (TLIS) Investors and Encourages Investors to Contact the Firm Before March 8, 2022

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Talis...

TLIS : 2.8400 (+77.50%)
Shareholder Alert: Robbins LLP Reminds Investors that Talis Biomedical Corporation (TLIS) is Being Sued for Misleading Shareholders

Shareholder rights law firm Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Talis Biomedical Corporation...

TLIS : 2.8400 (+77.50%)

Business Summary

Talis Biomedical Corporation engaged in developing and commercializing products for infectious diseases at the point-of-care. The company involved in developing the Talis One platform, a compact, sample-to-answer, cloud-enabled, molecular diagnostic platform. Talis Biomedical Corporation is based in...

See More

Key Turning Points

3rd Resistance Point 2.8933
2nd Resistance Point 2.8667
1st Resistance Point 2.8533
Last Price 2.8400
1st Support Level 2.8133
2nd Support Level 2.7867
3rd Support Level 2.7733

See More

52-Week High 2.8400
Last Price 2.8400
Fibonacci 61.8% 2.1524
Fibonacci 50% 1.9400
Fibonacci 38.2% 1.7276
52-Week Low 1.0400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar